.svg) | |
| Long title | An Act To amend the Public Health Service Act to provide for research, information, and education with respect to blood cancer. |
|---|---|
| Enacted by | the107th United States Congress |
| Citations | |
| Public law | Pub. L. 107–172 (text)(PDF) |
| Statutes at Large | 116 Stat. 541 |
| Codification | |
| Acts amended | Public Health Service Act |
| Legislative history | |
| |
TheHematological Cancer Research Investment and Education Act of 2001 (Pub. L. 107–172 (text)(PDF)) amends thePublic Health Service Act to allocate funding and establish directed research and education programs targeted at forms ofblood cancer, in particularleukemia,lymphoma, andmultiple myeloma.[1]
The bill was introduced as S. 1094 by SenatorKay Bailey Hutchison of Texas in June 2001. Hutchinson's brother has had multiple myeloma and she worked for several years to pass legislation of this type.[2] The bill came out through theSenate Committee on Health, Education, Labor, and Pensions, and passed theUnited States Senate by unanimous consent in November 2001. It went through theHouse Committee on Energy and Commerce and passed theU.S. House of Representatives on a voice vote in April 2002. It was signed into law by PresidentGeorge W. Bush on May 14, 2002.[1]
The research provision of the bill, the Joe Moakley Research Excellence Program, requires the Director of theNational Institutes of Health, through theNational Cancer Institute, to expand and coordinate blood cancer research programs.[1] It was named after former Massachusetts CongressmanJoe Moakley, who died in May 2001 ofmyelodysplastic syndrome, a form of leukemia.[3] The education provision of the bill, the Geraldine Ferraro Cancer Education Program, requires theSecretary of Health and Human Services to establish an education program for patients of such blood cancers and the general public.[1] It is named after former New York Congresswoman and 1984 Democratic vice-presidential nomineeGeraldine Ferraro, who has been battling multiple myeloma since 1998.[4] Ferraro did not publicly disclose her disease until June 2001, when she appeared in Congressional hearings to advocate for passage of the Act.[4]
An example of the Moakley program funding is $12.75 million toThe University of Texas M. D. Anderson Cancer Center.[5] The Ferraro program was not funded in 2003,[5] but received $5 million funding in 2004.[2]